Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer

This study investigated the oncologic impact of loss of SMAD4 expression in resected left-sided pancreatic cancer and its correlation with tumor metabolism. From 2005 to 2011, the medical records of patients who underwent radical distal pancreatectomy for resectable pancreatic cancer were retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chang Moo, Hwang, Ho Kyoung, Park, Jiae, Kim, Changsoo, Cho, Seong-Kyoung, Yun, Mijin, Lee, Woo Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998702/
https://www.ncbi.nlm.nih.gov/pubmed/27124039
http://dx.doi.org/10.1097/MD.0000000000003452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998702/
https://www.ncbi.nlm.nih.gov/pubmed/27124039
http://dx.doi.org/10.1097/MD.0000000000003452

Ejemplares similares